Developer docs
API playgroundTry for free, no card

Search company profiles

Almatica Pharma

Full company profile

uuid000btb6

Namestring
Almatica Pharma
Legal namestring
Almatica Pharma LLC
Websiteurl
almatica.com
Company typeenum
Private
Founded yearint
2009
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersMorristown, United States
HQ citystring
Morristown
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
generic pharmaceuticals, CNS medications, psychiatry neurology drugs, specialty pharmaceutical products, prescription drug development
Industry2 codes
PRIMARYHLAIACAC
Neurology & CNS Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code1 code
  • Pharmaceutical Preparation Manufacturing325412
SIC code1 code
  • Pharmaceutical Preparations2834
Product category
Specialty Pharmaceuticals
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Pharmaceutical product sales
TypeOne Time License
Description

Almatica generates revenue through the sale of prescription pharmaceutical products in the CNS (psychiatry and neurology) therapeutic areas, as well as established products covering pain management, neurology, anti-infectives, and cardiovascular diseases.

almatica.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Almatica Pharma is a specialty pharmaceutical company that develops, acquires, and commercializes prescription medications focused on the central nervous system (CNS) therapeutic areas of psychiatry and neurology. The company operates two product portfolios: a CNS portfolio (including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem) and an established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). Almatica also maintains a development pipeline of CNS candidates targeting depression, bipolar disorder, and anxiety.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Almatica Pharma is a specialty pharmaceuticals company and subsidiary of Alvogen, focused on developing innovative medicines within the CNS (central nervous system) therapeutic area covering psychiatry and neurology. The company operates two product portfolios: (1) A CNS portfolio consisting of mental health and neurologic medications including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem; and (2) An established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). The company maintains a pipeline of CNS candidates including ALM003, ALM008, ALM009, ALM013, and ALM014 targeting depression, bipolar disorder, and anxiety conditions. Patient support includes copay savings programs for several products.

Product and service10 records
1Escitalopram
CategoryCNS Product
Description

Escitalopram is an SSRI antidepressant medication for the treatment of mental health conditions including depression and anxiety. The product carries a Boxed Warning and is available by prescription through the dedicated product website.

2Loreev XR
CategoryCNS Product
Description

Loreev XR (lorazepam) is an extended-release capsule medication indicated for mental health conditions, specifically anxiety disorders. The product carries a Boxed Warning and is available by prescription.

3Sertraline
CategoryCNS Product
Description

Sertraline HCl capsules are an SSRI antidepressant medication for the treatment of mental health conditions including depression, anxiety, and related disorders. The product carries a Boxed Warning.

4Citalopram
CategoryCNS Product
Description

Citalopram is an SSRI medication used for the treatment of mental health and neurologic conditions. The product carries a Boxed Warning and is available by prescription.

5Venlafaxine
CategoryCNS Product
Description

Venlafaxine is an SNRI antidepressant medication indicated for the treatment of mental health and neurologic conditions including depression and anxiety disorders. The product carries a Boxed Warning.

6Zolpidem
CategoryCNS Product
Description

Zolpidem is a sedative-hypnotic medication indicated for the treatment of sleep and neurologic conditions such as insomnia. The product carries a Boxed Warning.

7Gralise
CategoryEstablished Product - Pain Management
Description

Gralise (gabapentin) is an oral tablet medication indicated for pain management, specifically for the management of postherpetic neuralgia. Available by prescription.

8Macrobid
CategoryEstablished Product - Anti-infective
Description

Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg capsules are an anti-infective medication indicated for the treatment of urinary tract infections. NDC: 52427-285-01.

9Macrodantin
CategoryEstablished Product - Anti-infective
Description

Macrodantin (nitrofurantoin macrocrystals) capsules are an anti-infective medication available in 25 mg, 50 mg, and 100 mg strengths for the treatment of urinary tract infections.

10Zestoretic
CategoryEstablished Product - Cardiovascular
Description

Zestoretic (lisinopril and hydrochlorothiazide) is a cardiovascular combination medication available in 10 mg-12.5 mg, 20 mg-12.5 mg, and 20 mg-25 mg strengths for the treatment of hypertension. The product carries a Boxed Warning.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Almatica is a subsidiary of Alvogen. The company operates as Alvogen's specialty pharmaceuticals subsidiary focused on innovative medicines in psychiatry and neurology. Alvogen's CEO Divya Patel was appointed as CEO of Almatica in January 2026.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based specialty generics pharma with a meaningful CNS/neurology portfolio, comparable in scale and go-to-market to Almatica. Both target psychiatrists and neurologists with branded and generic CNS products distributed through US pharmacy channels.

TypeDirect peer
Description

Specialty pharma focused on CNS disorders including ADHD, epilepsy, and depression. Comparable to Almatica's CNS specialty positioning and overlap on psychiatry/neurology prescribing audiences.

TypeDirect peer
Description

Specialty pharma with a portfolio anchored in CNS/neurology indications including psychiatry and neurology. Comparable therapy-area focus and US specialty distribution model to Almatica.

TypeDirect peer
Description

US-focused specialty and generic pharma with significant CNS presence across neurology and psychiatry. Directly comparable hybrid specialty/generic model and similar product mix to Almatica.

TypeDirect peer
Description

US generic pharmaceutical manufacturer with a portfolio that includes CNS and other therapeutic categories. Comparable generic-pharma model with US distribution and similar institutional customer base.

TypeBroad incumbent
Description

World's largest generic drug manufacturer with a broad CNS portfolio including neurology and psychiatry products. Overlaps with Almatica's generic CNS franchise but operates at significantly larger scale across many therapeutic areas.

TypeBroad incumbent
Description

Global generics and specialty pharma (formed from Mylan/Pfizer Upjohn) with significant CNS franchise. Comparable generic-and-specialty pharma positioning but with vastly broader geographic and therapeutic footprint than Almatica.

8Sandoz
TypeBroad incumbent
Description

Novartis's generics and biosimilars division with a sizable CNS portfolio and global manufacturing scale. Comparable generics business model but operates at significantly broader scale and therapeutic breadth than Almatica.

TypeDirect peer
Description

Canadian-headquartered generic pharmaceutical manufacturer with US operations selling into comparable pharmacy distribution channels. Comparable generics business model with overlapping CNS and adjacent therapeutic categories.

TypeBroad incumbent
Description

Diversified specialty pharma with neurology and broader CNS exposure (Salix, Bausch + Lomb). Comparable specialty pharma go-to-market and overlap on US prescriber channels, though at substantially larger scale and breadth.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Almatica Pharma

Specialty Pharmaceuticalsalmatica.com

Almatica Pharma firmographics

Firmographics
Name
Almatica Pharma
Legal name
Almatica Pharma LLC
Website
https://almatica.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
51–100 employees
Ownership category
akta.pro rank

Almatica Pharma industry classification

Industry
Product category
Specialty Pharmaceuticals
NAICS
Pharmaceutical Preparation Manufacturing (325412)
SIC
Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIACAC
Neurology & CNS Specialty Pharmaceuticals
SECONDARYHLAIAAAB
Specialty Care Pharmaceuticals
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • Generic pharmaceuticals
  • CNS medications
  • Psychiatry neurology drugs
  • Specialty pharmaceutical products
  • Prescription drug development

Where Almatica Pharma is headquartered

Location

Headquarters

HQ city
Morristown
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Almatica Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Technology or R&D, Personnel, Marketing or Sales, Supply Chain, Others

Revenue model

  1. Pharmaceutical product sales: Almatica generates revenue through the sale of prescription pharmaceutical products in the CNS (psychiatry and neurology) therapeutic areas, as well as established products covering pain management, neurology, anti-infectives, and cardiovascular diseases.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Almatica Pharma product offering

Product offering

Core offering

Almatica Pharma is a specialty pharmaceutical company that develops, acquires, and commercializes prescription medications focused on the central nervous system (CNS) therapeutic areas of psychiatry and neurology. The company operates two product portfolios: a CNS portfolio (including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem) and an established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). Almatica also maintains a development pipeline of CNS candidates targeting depression, bipolar disorder, and anxiety.

Product overview

Almatica Pharma is a specialty pharmaceuticals company and subsidiary of Alvogen, focused on developing innovative medicines within the CNS (central nervous system) therapeutic area covering psychiatry and neurology. The company operates two product portfolios: (1) A CNS portfolio consisting of mental health and neurologic medications including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem; and (2) An established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). The company maintains a pipeline of CNS candidates including ALM003, ALM008, ALM009, ALM013, and ALM014 targeting depression, bipolar disorder, and anxiety conditions. Patient support includes copay savings programs for several products.

Differentiator

Problem solved

Functional benefit

Products and services

  • Escitalopram Escitalopram is an SSRI antidepressant medication for the treatment of mental health conditions including depression and anxiety. The product carries a Boxed Warning and is available by prescription through the dedicated product website.
  • Loreev XR Loreev XR (lorazepam) is an extended-release capsule medication indicated for mental health conditions, specifically anxiety disorders. The product carries a Boxed Warning and is available by prescription.
  • Sertraline Sertraline HCl capsules are an SSRI antidepressant medication for the treatment of mental health conditions including depression, anxiety, and related disorders. The product carries a Boxed Warning.
  • Citalopram Citalopram is an SSRI medication used for the treatment of mental health and neurologic conditions. The product carries a Boxed Warning and is available by prescription.
  • Venlafaxine Venlafaxine is an SNRI antidepressant medication indicated for the treatment of mental health and neurologic conditions including depression and anxiety disorders. The product carries a Boxed Warning.
  • Zolpidem Zolpidem is a sedative-hypnotic medication indicated for the treatment of sleep and neurologic conditions such as insomnia. The product carries a Boxed Warning.
  • Gralise Gralise (gabapentin) is an oral tablet medication indicated for pain management, specifically for the management of postherpetic neuralgia. Available by prescription.
  • Macrobid Macrobid (nitrofurantoin monohydrate/macrocrystals) 100 mg capsules are an anti-infective medication indicated for the treatment of urinary tract infections. NDC: 52427-285-01.
  • Macrodantin Macrodantin (nitrofurantoin macrocrystals) capsules are an anti-infective medication available in 25 mg, 50 mg, and 100 mg strengths for the treatment of urinary tract infections.
  • Zestoretic Zestoretic (lisinopril and hydrochlorothiazide) is a cardiovascular combination medication available in 10 mg-12.5 mg, 20 mg-12.5 mg, and 20 mg-25 mg strengths for the treatment of hypertension. The product carries a Boxed Warning.

Companies that use Almatica Pharma

Customer profile

Segments2 records

Ideal customer profiles3 records

Almatica Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Almatica Pharma partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • AlvogencoreStrategic or Co-development PartnerAlmatica is a subsidiary of Alvogen. The company operates as Alvogen's specialty pharmaceuticals subsidiary focused on innovative medicines in psychiatry and neurology. Alvogen's CEO Divya Patel was appointed as CEO of Almatica in January 2026.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Almatica Pharma competitors and assessment

Company assessment

Direct peers

  • Upsher-Smith: US-based specialty generics pharma with a meaningful CNS/neurology portfolio, comparable in scale and go-to-market to Almatica. Both target psychiatrists and neurologists with branded and generic CNS products distributed through US pharmacy channels.
  • Supernus Pharmaceuticals: Specialty pharma focused on CNS disorders including ADHD, epilepsy, and depression. Comparable to Almatica's CNS specialty positioning and overlap on psychiatry/neurology prescribing audiences.
  • Jazz Pharmaceuticals: Specialty pharma with a portfolio anchored in CNS/neurology indications including psychiatry and neurology. Comparable therapy-area focus and US specialty distribution model to Almatica.
  • Amneal Pharmaceuticals: US-focused specialty and generic pharma with significant CNS presence across neurology and psychiatry. Directly comparable hybrid specialty/generic model and similar product mix to Almatica.
  • Lannett: US generic pharmaceutical manufacturer with a portfolio that includes CNS and other therapeutic categories. Comparable generic-pharma model with US distribution and similar institutional customer base.
  • Apotex: Canadian-headquartered generic pharmaceutical manufacturer with US operations selling into comparable pharmacy distribution channels. Comparable generics business model with overlapping CNS and adjacent therapeutic categories.

Broad incumbents

  • Teva Pharmaceutical Industries: World's largest generic drug manufacturer with a broad CNS portfolio including neurology and psychiatry products. Overlaps with Almatica's generic CNS franchise but operates at significantly larger scale across many therapeutic areas.
  • Viatris: Global generics and specialty pharma (formed from Mylan/Pfizer Upjohn) with significant CNS franchise. Comparable generic-and-specialty pharma positioning but with vastly broader geographic and therapeutic footprint than Almatica.
  • Sandoz: Novartis's generics and biosimilars division with a sizable CNS portfolio and global manufacturing scale. Comparable generics business model but operates at significantly broader scale and therapeutic breadth than Almatica.
  • Bausch Health: Diversified specialty pharma with neurology and broader CNS exposure (Salix, Bausch + Lomb). Comparable specialty pharma go-to-market and overlap on US prescriber channels, though at substantially larger scale and breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Almatica Pharma social profiles

Digital presence

Almatica Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Almatica Pharma leadership team

Management profile

Number of profiles

Profiles2 records

Almatica Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Almatica Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Almatica Pharma

What does Almatica Pharma do?

Almatica Pharma is a specialty pharmaceutical company that develops, acquires, and commercializes prescription medications focused on the central nervous system (CNS) therapeutic areas of psychiatry and neurology. The company operates two product portfolios: a CNS portfolio (including Escitalopram, Loreev XR, Sertraline, Citalopram, Venlafaxine, and Zolpidem) and an established products portfolio covering pain management (Gralise), anti-infectives (Macrobid, Macrodantin), and cardiovascular diseases (Zestoretic). Almatica also maintains a development pipeline of CNS candidates targeting depression, bipolar disorder, and anxiety.

Is Almatica Pharma a public or private company?

Almatica Pharma is a private company. It is classified as corporate owned and is currently operating.

When was Almatica Pharma founded?

Almatica Pharma was founded in 2009. It employs 51 to 100 people.

Where is Almatica Pharma based?

Almatica Pharma is headquartered in Morristown, United States, in the North America region.

How does Almatica Pharma make money?

One revenue line is on record: pharmaceutical product sales.

Who are Almatica Pharma's main competitors?

Direct peers on record are Upsher-Smith, Supernus Pharmaceuticals, Jazz Pharmaceuticals, Amneal Pharmaceuticals, Lannett and Apotex. Broad incumbents are Teva Pharmaceutical Industries, Viatris, Sandoz and Bausch Health.

Does Almatica Pharma have an API?

No public API is recorded for Almatica Pharma.

What industry is Almatica Pharma in?

Almatica Pharma's product category is Specialty Pharmaceuticals. Its primary akta.pro industry code is HLAIACAC, Neurology & CNS Specialty Pharmaceuticals, with a secondary code of HLAIAAAB, Specialty Care Pharmaceuticals. Its NAICS code is 325412 and its SIC code is 2834.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales